A high profit & rapid growth venture addressing serious and costly post-operative complications related to 2.7MM sternotomy procedures/year. ThoraGraft provides a solution to an unmet problem with significant clinical challenges and costs. Portfolio of patent pending graft technologies addressing sternal healing, fusion, patient outcomes & quality of care metrics. A high rate of return investment with a reduced cost and mitigated risk profile.